Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
Rank in Stocks #96
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Share Price
$43.92
Last synced: 2026-09-11
Market Cap
$195.10B
Change (1 day)
-3.37%
Change (1 year)
-17.97%
Country
DK
Trade Novo Nordisk A/S (NOVO-B)

Category

Stock price history for Novo Nordisk A/S (NOVO-B)
Highest end of day price: $45.23 on 2026-09-01

Lowest end of day price: $6.85 on 2010-02-01
Stock price history of Novo Nordisk A/S from 2010 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -3.05%
2025 -51.49%
2024 1.66%
2023 53.39%
2022 17.33%
2021 57.90%
2020 22.88%
2019 26.30%
2018 -13.92%
2017 49.76%
2016 -37.96%
2015 26.26%
2014 24.70%
2013 10.83%
2012 43.56%
2011 6.06%
2010 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$1.11K 47.49%
US
$265.87 49.31%
US
$257.01 17.71%
US
$459.10 30.72%
CH
$144.05 73.95%
US